ARB might be superior to ACEI for treatment of hypertensive COVID‐19 patients - Zhao - 2021 - Journal of Cellular and Molecular Medicine - Wiley Online Library
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial - The Lancet Respiratory Medicine
Frontiers | Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
There's just been AKI. So what do we do with the ACEi/ARB? — NephJC
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research
Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea | Scientific Reports
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials | BMC Cardiovascular Disorders | Full Text
Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria | Hypertension
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection | BMJ Open
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - ScienceDirect
Should ACE-inhibitors and ARBs be stopped with COVID-19? — NephJC
Cureus | Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study | Article
ARBs in HFrEF (ELITE I & II, CHARM-Alternative, CHARM-Added & Val-HeFT) — NERDCAT
Frontiers | Withholding vs. Continuing Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Before Non-cardiac Surgery in Older Patients: Study Protocol for a Multicenter Randomized Controlled Trial
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking | Critical Care | Full Text
Side Effects of ACEi/ARBs During Pregnancy | Calgary Guide
JCM | Free Full-Text | Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias
Nutrients | Free Full-Text | ACEI-Inhibitory Peptides Naturally Generated in Meat and Meat Products and Their Health Relevance
Inhibition of angiotensin converting enzyme induces mechanical allodynia through increasing substance P expression in mice - ScienceDirect
ACE Inhibitors - almostadoctor
Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis | PLOS Computational Biology
ACE inhibitor - Wikipedia
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension? | SpringerLink
Therapeutics Initiative | How do you prescribe ACEIs and ARBs for hypertension?
Cross-Reactivity of ACE Inhibitor–Induced Angioedema with ARBs
